ES8800253A1 - Un procedimiento para preparar derivados sinteticos de pseudopterosina - Google Patents

Un procedimiento para preparar derivados sinteticos de pseudopterosina

Info

Publication number
ES8800253A1
ES8800253A1 ES553952A ES553952A ES8800253A1 ES 8800253 A1 ES8800253 A1 ES 8800253A1 ES 553952 A ES553952 A ES 553952A ES 553952 A ES553952 A ES 553952A ES 8800253 A1 ES8800253 A1 ES 8800253A1
Authority
ES
Spain
Prior art keywords
pseudopterosin
hydrogen
carbon atoms
synthetic
synthetic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553952A
Other languages
English (en)
Other versions
ES553952A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of ES553952A0 publication Critical patent/ES553952A0/es
Publication of ES8800253A1 publication Critical patent/ES8800253A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS SINTETICOS DE SEUDOPTEROSINA. COMPRENDE. A) HACER REACCIONAR A SEUDOPTEROSINA DE FORMULA (II) CON ACIDO METACLOROPERBENZOICO, EN PRESENCIA DE PIRIDINA, A TEMPERATURA AMBIENTE Y DURANTE 20 A 80 HORAS, PARA OBTENER UN COMPUESTO DE FORMULA (I) (R6, OXIDO DE BUTILO); Y B) TRATAR A (I) CON ETERATO DE TRIFLUORURO DE BORO, EN ETER DIETILICO ANHIDRO A 0G Y DURANTE 20 MINUTOS, PARA OBTENER UN COMPUESTO DE FORMULA (I) (R3, 1-CETO-2-METILPROPANO). SIENDO: R1, R2, R3, R4 Y R5, H. SE UTILIZAN COMO ANTI-PROLIFERANTES Y ANALGESICOS. *FORMULA* A
ES553952A 1985-04-15 1986-04-14 Un procedimiento para preparar derivados sinteticos de pseudopterosina Expired ES8800253A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/723,214 US4745104A (en) 1985-04-15 1985-04-15 Pseudopterosin and synthetic derivatives thereof

Publications (2)

Publication Number Publication Date
ES553952A0 ES553952A0 (es) 1987-11-01
ES8800253A1 true ES8800253A1 (es) 1987-11-01

Family

ID=24905341

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553952A Expired ES8800253A1 (es) 1985-04-15 1986-04-14 Un procedimiento para preparar derivados sinteticos de pseudopterosina

Country Status (10)

Country Link
US (1) US4745104A (es)
EP (1) EP0198689A3 (es)
JP (1) JP2748001B2 (es)
AU (1) AU5606586A (es)
CA (1) CA1288771C (es)
DK (1) DK162686A (es)
ES (1) ES8800253A1 (es)
GR (1) GR860899B (es)
PT (1) PT82395B (es)
ZA (1) ZA862488B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849410A (en) * 1985-04-15 1989-07-18 The Regents Of The University Of California Pseudopterosin and synthetic derivatives thereof
US5416356A (en) * 1993-09-03 1995-05-16 Motorola, Inc. Integrated circuit having passive circuit elements
US5624911A (en) * 1995-06-07 1997-04-29 The Regents Of The University Of California Ether derivatives of pseudopterosin
US5597808A (en) * 1995-06-07 1997-01-28 Osteoarthritis Sciences, Incorporated Use of pseudopterosins for promoting wound healing
US6217913B1 (en) 1999-07-15 2001-04-17 Fatemeh Mohammadi Cosmetic compositions with gorgonian extract
AU2002241521B2 (en) 2000-11-28 2005-10-20 The Regents Of The University Of California Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
EP1651241A2 (en) * 2003-07-28 2006-05-03 The Regents of the University of California, Office of Technology Transfer, University of California Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds
EP1732500B1 (en) * 2004-01-07 2018-11-21 E-L Management Corporation Cosmetic composition and method for retarding hair growth
CN101688172A (zh) * 2007-04-30 2010-03-31 爱德华王子岛大学 拟珊瑚素生产细菌及其使用方法
WO2010085811A2 (en) * 2009-01-26 2010-07-29 Taipei Medical University Use of pterosin compounds for treating diabetes and obesity
EP2353597A1 (en) * 2010-01-13 2011-08-10 Universität zu Köln Arene chromium-carbonyl complexes, method for their preparation of and use thereof as pharmaceuticals
US9180112B2 (en) * 2010-03-23 2015-11-10 Ermis Labs, LLC Dermal compositions containing gorgonian extract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation

Also Published As

Publication number Publication date
PT82395B (en) 1987-10-14
EP0198689A3 (en) 1987-06-10
PT82395A (en) 1986-05-01
ZA862488B (en) 1986-11-26
DK162686D0 (da) 1986-04-10
JP2748001B2 (ja) 1998-05-06
CA1288771C (en) 1991-09-10
AU5606586A (en) 1986-10-23
EP0198689A2 (en) 1986-10-22
GR860899B (en) 1986-08-07
DK162686A (da) 1986-10-16
ES553952A0 (es) 1987-11-01
JPS6236395A (ja) 1987-02-17
US4745104A (en) 1988-05-17

Similar Documents

Publication Publication Date Title
AU583439B2 (en) Prodrugs of rapamycin
ES8400730A1 (es) Un procedimiento para preparar derivados de tetralina
ATE23716T1 (de) 5,6,7-trinor-4,8-inter-m-phenylen-prostaglandin i2-derivate.
ES8800253A1 (es) Un procedimiento para preparar derivados sinteticos de pseudopterosina
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES8506635A1 (es) Un procedimiento para la preparacion de derivados de acilmorfinano
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
AU2622595A (en) Novel processes and intermediates for the preparation of piperazine derivatives
ES8203342A1 (es) Metodo de preparar nuevos derivados de taurina
MX170732B (es) Composicion de derivados de succinimida y su uso
ES8402288A1 (es) Proceso de produccion de los derivados de la piperacina.
ES468630A1 (es) Procedimiento para la obtencion de derivados de la isoquino-leina.
GR860021B (en) Octahydro indolizine compounds useful as analgesics
ES8502962A1 (es) Un procedimiento para preparar un derivado de acido bifenililpropionico
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES474986A1 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES2000209A6 (es) Un procedimiento para preparar derivados de benceno
ES2056721A1 (es) Mejoras en el objeto de la patente de invencion n{ 9101355 que se refiere a procedimiento de obtencion de nuevos derivados de platino con aminopirrolidinas.
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
DE3768449D1 (en) 4-hydroxy-4-(substituierte alkenyl)-cyclohexancarbonsaeure.
ES8602607A1 (es) Un procedimiento para preparar sales de compuestos de fenantreno-metanol
ES8607944A1 (es) Procedimiento para la preparacion de nuevos derivados de 1- fenilimidazolidin-2-ona
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.